a friendly atmosphere that keeps you smiling
Edward
Street Dental is now offering OraVerse to patients who don’t want that
lingering numbness after local anesthetics.
After administrating OraVerse, a patient can return to normal sensation
twice as fast. In clinical trials, patients
have reported a return as quickly as 30 minutes after receiving OraVerse.
OraVerse is the first and only local anesthesia reversal
agent that accelerates the return to normal sensation and function for patients
who want to avoid the unwanted and unnecessary lingering soft tissue numbness following
routine dental procedures. The
first-in-class product was officially launched earlier this year by the
The average duration of soft tissue numbness following the
use of a local dental anesthetic is 3-5 hours. Numbness can lead to functional
deficits. These deficits can result in difficulty with speaking, smiling,
eating, drinking, biting of lip or cheek and uncontrolled drooling as well as
give the patient a perceived sense of altered appearance. OraVerse has been proven to return a
patient’s normal sensation twice as fast.
OraVerse has an excellent safety profile. There are no contraindications and no known
drug interactions with OraVerse. In
clinical trials involving over 700 patients, there was no significant difference
in adverse events versus control.
About OraVerse®
OraVerse (phentolamine mesylate) Injection is the first and only local dental anesthesia reversal agent that accelerates the return to normal sensation and function following restorative and periodontal maintenance procedures. OraVerse is indicated for the reversal of soft tissue anesthesia, i.e., anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor. OraVerse is indicated for use only in adults and children 6 years of age or older and weighing at least 15 kg (33 lbs). For more information visit www.oraverse.com